ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

DEA reconsidering Schedule I ruling of CBD after Epidiolex approval

Updated on July 30, 2018
jfsigerson profile image

Finance journalist • Interests: crypto, crowdfunding, tech, marketing • Stocks: biotech, healthcare, commodities, IT • Whiskey enthusiast.

Source

As a whole, the cannabis industry has come a long way. It’s always inspiring to see how the people behind its newly acquired reputation have worked so hard to get where it is today.

Nevertheless, while celebrations and praises are due, the industry still faces an uphill battle before being considered entirely legal worldwide.

Drug evolution

Many companies are taking steps towards breaking the chains put in cannabis products including hemp derivatives and cannabidiol (CBD) oils.

In June alone, the US Food and Drug Administration (FDA) gave the go signal for GW Pharmaceuticals’ Epidiolex to be used as a treatment for seizures that are associated with two rare forms of epilepsy — Lennox Gastaut syndrome and Dravet syndrome.

Epidiolex is the first FDA-approved drug that contains a purified drug substance that was derived from marijuana.

Source

Reclassification

After this development, the US Drug Enforcement Agency (DEA) has put the focus on readdressing cannabis as a Schedule I Drug.

All marijuana products are under this classification—even CBD oils that do not contain the psychoactive Tetrahydrocannabinol (THC) compound. Items under the Schedule I Drug classification are considered to have high abuse potential with no medical benefits.

Many have criticized the classification of marijuana products, considering the scientific studies that back its health benefits. From a broader perspective, marijuana is put under the same classification as heroin and cocaine.

Schedule ruling

The DEA is now going to address the Schedule I ruling within a span of 3 months.

Indeed, there are expectations to reclassify CBD as a Schedule II or Schedule III drug, with thanks to companies like GW Pharmaceuticals. Under these two, CBD products will be considered as addictive, but its medical benefits will be taken into consideration as well.

If it falls under the Schedule II ruling, CBD will be in line with opioid drugs. If Schedule III is chosen, it will be in the same category as testosterone treatments and Tylenol with Codeine.

Source

Better CBD prospects

Aside from the Epidiolex manufacturer, there are also other companies that help generate a better outlook on CBD. One such company is PotNetwork Holdings, Inc. (OTCMKTS:POTN) and its subsidiary, Diamond CBD, Inc.

POTN focuses heavily on the research and development of CBD products. The company uses a meticulous process called supercritical CO2 extraction to isolate the naturally occurring beneficial compounds of hemp. What comes out of the process are pure CBD oils that Diamond CBD uses to help create and distribute the best products in the industry.

POTN has set itself as one of the prime examples of a good CBD company through its products, sales figures, and healthy business practices. The company is always willing to improve its services for the benefit of its clients and investors alike.

In a recent announcement, the company has formally filed a registration statement on Form 10 with the Securities and Exchange Commission (SEC). Through it, POTN has become a fully reporting SEC company which opens up its share to a broader pool of investors. This new announcement follows the company’s decision to begin taking steps into changing its name into BioTech Hemp, Inc.

Moreover, Diamond CBD has shown consistently improving sales for 2018. In the most recent financial report, it was revealed that the CBD distributor achieved over $2 million in revenues, thereby continuing its trend of breaking new record sales year after year. Most of Diamond CBD’s sales were made through internet transactions which showcase the company’s strong presence online.

Both GW Pharmaceuticals and POTN are busy with their projects. These recent announcements not only benefit the company but the entire CBD industry as well. In time, CBD products will be given a more positive outlook, and it will be able to reach out to more people that direly need the health benefits of cannabis.

working

This website uses cookies

As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://corp.maven.io/privacy-policy

Show Details
Necessary
HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
LoginThis is necessary to sign in to the HubPages Service.
Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
AkismetThis is used to detect comment spam. (Privacy Policy)
HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
Features
Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
MavenThis supports the Maven widget and search functionality. (Privacy Policy)
Marketing
Google AdSenseThis is an ad network. (Privacy Policy)
Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
Index ExchangeThis is an ad network. (Privacy Policy)
SovrnThis is an ad network. (Privacy Policy)
Facebook AdsThis is an ad network. (Privacy Policy)
Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
AppNexusThis is an ad network. (Privacy Policy)
OpenxThis is an ad network. (Privacy Policy)
Rubicon ProjectThis is an ad network. (Privacy Policy)
TripleLiftThis is an ad network. (Privacy Policy)
Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
Statistics
Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)
ClickscoThis is a data management platform studying reader behavior (Privacy Policy)